| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.683994984648504 3.6231736949445423 0.0002910102588269 0.1597446633195612 0.1740241347785109 46 O14949,P24539,P00403,Q9UDW1,O43676,P12235,P20674,O96000,P21912,O75964,P14406,P05141,Q9Y6M9,P22695,P47985,O75880,P13073,P12236,P56385,O95168 20 |
| Nonalcoholic fatty liver disease 0.6034137576507709 3.3231239889060187 0.0008901533934577 0.4128933502401081 0.1836240008386295 52 O14949,O14920,P00403,Q86Y39,Q9UDW1,O00459,O43676,P20674,P08574,O96000,P21912,P14927,P51970,P31751,P14406,Q9Y6M9,P22695,P47985,P13073,Q9P0J0,O75306,P54646,O00483,P31930,O95168,Q9Y478 26 |
| Oxidation by cytochrome p450 0.8727175628469832 2.47819970225606 0.0132047214289228 0.9996469927618092 0.6436816246862345 6 Q16850,O43169,Q6UW02 3 |
| Sphingolipid metabolism overview 0.8502105542577448 2.437905678687402 0.0147726279964444 0.9998636018391652 0.6436816246862345 9 O95470,O15269,Q16739,Q9NRA0,Q06136,Q13510,Q96G23 7 |
| Sphingolipid metabolism integrated pathway 0.8502105542577448 2.437905678687402 0.0147726279964444 0.9998636018391652 0.6436816246862345 9 O95470,O15269,Q16739,Q9NRA0,Q06136,Q13510,Q96G23 7 |
| Mitochondrial complex iv assembly 0.8091723323900112 2.272450369264005 0.0230593224076192 0.9999991266678993 0.6436816246862345 10 Q9Y2R0,P00403,P13073,P14406,P20674 5 |
| Proteoglycan biosynthesis 0.8243666085533352 2.2672727275803592 0.0233735704189292 0.9999992795117946 0.6436816246862345 6 Q9NX62,Q8NCH0,Q8TB61 3 |
| Glycerophospholipid biosynthetic pathway 0.8128766982378924 2.2503181596532693 0.0244287559844038 0.9999996225352974 0.6436816246862345 8 Q9BTU6,Q9Y6K0,O95674,O00116,Q9HCL2,O14735 6 |
| Metabolism of spingolipids in er and golgi apparatus 0.8598567424478203 2.24216561009261 0.0249506708777822 0.9999997259060058 0.6436816246862345 5 O95470,Q06136,Q10472,Q9NRA0 4 |
| Sphingolipid pathway 0.7948616075064601 2.2061555498696483 0.0273731103557635 0.9999999380743312 0.6436816246862345 10 O95470,O15269,Q96G23,Q06136,Q13510,P04062,Q9NRA0 7 |
| Sphingolipid metabolism in senescence 0.7824020697181421 2.1901897106441575 0.0285104811541097 0.9999999692393547 0.6436816246862345 12 O15269,P16278,Q06136,Q13510,P04062,Q96G23 6 |
| Statin inhibition of cholesterol production 0.8467767050762927 2.18674650367809 0.0287610347278521 0.9999999736362996 0.6436816246862345 5 Q8WTV0,Q14534,P37268,P04035 4 |
| Kennedy pathway from sphingolipids 0.834522007438243 2.1345062495528193 0.0328013626257392 0.9999999978204128 0.6436816246862345 5 O95470,Q9Y6K0 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7717691930086703 2.031585468028154 0.0421956390785986 0.9999999999936388 0.6436816246862345 6 Q14739,Q16850,Q15125,Q15392 4 |
| Glycosaminoglycan degradation 0.7469508191402418 1.9181190070868095 0.0550959229093905 0.999999999999998 0.6436816246862345 6 P08236,P54802,P16278,P15586 4 |
| Degradation pathway of sphingolipids including diseases 0.7437718107186244 1.917031526439772 0.0552339265815144 0.9999999999999982 0.6436816246862345 7 O43681,P17900,P16278 3 |
| Mitochondrial immune response to sarscov2 0.7319838096637753 1.89182404880427 0.0585144279739886 0.9999999999999998 0.6436816246862345 9 Q9Y6M9,Q9Y375,Q7Z434,P35232,Q9Y276,Q99623 6 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7333194523451894 1.8682943797267193 0.0617210495969973 1.0 0.6436816246862345 7 Q9BXK5 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6889917244495122 1.8418910549744352 0.0654910873045422 1.0 0.6436816246862345 17 P50402,P55209,O75844,O60725 4 |
| Mitochondrial complex iii assembly 0.7132667495382035 1.8181198029860417 0.0690458238960984 1.0 0.6436816246862345 10 O14949,P31930,P22695,Q9Y276,P47985,Q9UDW1,Q6DKK2 7 |
| Familial partial lipodystrophy fpld 0.7123313878298352 1.7830494886197368 0.0745782477634426 1.0 0.6436816246862345 8 O75844,P20700,O60725,P31751,P49354,Q03252 6 |
| Omega3 omega6 fatty acid synthesis 0.7162754176631404 1.7759189013649537 0.0757462850790189 1.0 0.6436816246862345 6 Q15067,P33121,O15254 3 |
| Glycerolipids and glycerophospholipids 0.7466921605909582 1.7513007676327013 0.0798941155761601 1.0 0.6436816246862345 5 Q9HCL2,Q9UG56 2 |
| Mitochondrial complex i assembly model oxphos system 0.6178620054436259 1.6866486687619442 0.0916709277601037 1.0 0.6767804296363217 25 O96000,Q9Y6M9,Q9GZY4,Q96CU9,O95168,O43676,Q9P0J0,Q9NPL8 8 |
| Ferroptosis 0.6204460990478059 1.6668218759578275 0.095549828987006 1.0 0.6941790669339476 24 Q9NZZ3,Q15043,P04035,P37268,P16435,P02786,P33121,P09601,P45880,Q9UKU0,Q9Y277 11 |
| Zinc homeostasis 0.860877684407097 1.6447690762273035 0.1000174415989465 1.0 0.6941790669339476 3 Q8TAD4,Q15043 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7197134848956379 1.6306728245353184 0.1029593737008123 1.0 0.6941790669339476 5 P49354,Q03252,P20700,O60725 4 |
| Riboflavin and coq disorders 0.7777676455512181 1.619254252621667 0.1053925692975004 1.0 0.7002750715545026 4 Q16134 1 |
| Oxidative phosphorylation 0.5741566937946706 1.4899643685649728 0.1362336049997867 1.0 0.7809377184897393 27 P24539,Q9Y6M9,O96000,P56385,O75964,Q86Y39 6 |
| Nanomaterial induced apoptosis 0.6511867198600305 1.476848327848877 0.1397162986041982 1.0 0.7809377184897393 7 O95831,Q9NR28 2 |
| Omega9 fatty acid synthesis 0.6501816357764143 1.4626962229235856 0.1435505201584752 1.0 0.7809377184897393 6 P33121,O95864,O00767 3 |
| Copper homeostasis 0.6449827453750917 1.456886363980476 0.1451477507034049 1.0 0.7809377184897393 8 P35670,P05067,O75880 3 |
| Vitamin d metabolism 0.8104575163398571 1.4442513598616602 0.1486682824658884 1.0 0.7809377184897393 3 P38435,P04062 2 |
| Metapathway biotransformation phase i and ii 0.586869288030283 1.4343014861661214 0.1514862463960029 1.0 0.7809377184897393 23 Q86UY6,Q8NCH0,Q7LGA3,P21964,Q6UW02,Q16850,P21266 7 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6335807643244198 1.4234686527558422 0.154600343085465 1.0 0.7867126330506211 10 Q9UI14,Q9NR77 2 |
| S1p receptor signal transduction 0.6258210427080433 1.3727834826115963 0.1698196671221201 1.0 0.7996233144805343 9 Q13510,Q9NRA0 2 |
| Fatty acid transporters 0.6607713844880181 1.3632082893742428 0.1728168755174026 1.0 0.8037434267230372 5 Q9UKU0 1 |
| Influence of laminopathies on wnt signaling 0.6153903897892701 1.357171160727858 0.1747268318963124 1.0 0.8037434267230372 12 O75844,O60725 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5683629329289944 1.3523914011000635 0.1762501387619444 1.0 0.8045617021346775 24 Q14739,Q14534,Q9UBM7,Q9BWD1,Q15392,O00767,Q15125,Q15800,P04035,P37268,P35610,P33121,Q16850 13 |
| Glycosylation and related congenital defects 0.6000057597772847 1.2533405481497877 0.2100817977113798 1.0 0.8489680291594781 10 Q9BT22,Q9H3H5,Q2TAA5 3 |
| Striated muscle contraction pathway 0.6018852988031131 1.2289875152356364 0.2190764869870056 1.0 0.8489680291594781 6 P08670 1 |
| Urea cycle and related diseases 0.8805227131300581 1.1999038739728447 0.2301766752646155 1.0 0.8489680291594781 2 Q9UJS0 1 |
| Mevalonate pathway 0.5937796826170517 1.1894896753669968 0.2342470314570466 1.0 0.8489680291594781 6 Q9BWD1 1 |
| Triacylglyceride synthesis 0.6153937554239572 1.1548238329219953 0.2481625752725935 1.0 0.8605382540861183 5 Q9NUQ2,Q9HCL2,O00116 3 |
| Autosomal recessive osteopetrosis pathways 0.7350841312198408 1.143552209826581 0.2528093906840818 1.0 0.8605382540861183 3 P51798 1 |
| Tlr4 signaling and tolerance 0.6110004291395223 1.1346012644839665 0.2565424231074285 1.0 0.8605382540861183 5 O14920,Q15629 2 |
| Ccl18 signaling pathway 0.5743473271819961 1.1137052518933206 0.2654056554891879 1.0 0.8631748938444407 9 P00403,Q86UE4 2 |
| Endothelin pathways 0.5738006514595473 1.1035243999494644 0.2697995014469461 1.0 0.8631748938444407 8 P00403,P16615 2 |
| Irinotecan pathway 0.8534536403235916 1.0925219071014018 0.274603766766051 1.0 0.8631748938444407 2 P33527 1 |
| Progeriaassociated lipodystrophy 0.5644366034728707 1.0806598217866343 0.2798484616056231 1.0 0.8631748938444407 11 O75844,O60725 2 |
| Inclusion body myositis 0.7126629601911314 1.0547152859406874 0.2915555585980827 1.0 0.8787563321001421 3 Q92542 1 |
| Purinergic signaling 0.6250288232022309 0.9777588064521304 0.3281936292104332 1.0 0.8933240360986713 4 Q96RD7,P04899 2 |
| Aryl hydrocarbon receptor pathway wp2873 0.5624416069760214 0.9116038390082168 0.3619773007487752 1.0 0.898793224317702 5 P07900,P12931,O00170,Q15185 4 |
| Cellular proteostasis 0.5481158517595782 0.8463402928429773 0.3973629362332942 1.0 0.931855042617686 5 O15212,Q9UHV9,Q9NQP4,Q99471 4 |
| Sarscov2 and covid19 pathway 0.656023707842889 0.8342057175518419 0.4041650697959404 1.0 0.9420259170863324 3 Q8WTV0 1 |
| Vitamin d receptor pathway 0.5117381199684441 0.8311393011927695 0.4058949399379892 1.0 0.9420259170863324 14 Q92604,Q5VV42,Q8IWT6,Q96KA5 4 |
| Adipogenesis 0.5008440686217774 0.7928474499130628 0.4278667072666748 1.0 0.9442670080930076 16 O75844,Q16822 2 |
| Vitamin dsensitive calcium signaling in depression 0.5120662233994138 0.7927554222414949 0.4279203330990051 1.0 0.9442670080930076 7 P23634 1 |
| Camkk2 pathway 0.5027767965847103 0.7562072367910587 0.4495249545638327 1.0 0.9613015575078931 10 P09601 1 |
| Amyotrophic lateral sclerosis als 0.5026913656699652 0.7557738470501526 0.4497847995410957 1.0 0.9613015575078931 10 Q9BUN8 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4999544322789404 0.7525584722120731 0.4517152803674213 1.0 0.9613015575078931 12 Q5JRA6,P07237,Q96AY3,P13674,O75718 5 |
| Heme biosynthesis 0.5680178510469959 0.7426151235386309 0.4577147296127881 1.0 0.9614854562430624 4 P22830 1 |
| Alzheimers disease 0.3864053812495924 0.7300251928274731 0.4653747855061736 1.0 0.9614854562430624 85 P12236,O95197,P49721,P45880,Q9NQC3,Q92542,Q9Y277,P12235,P21796,P16615 10 |
| Ketogenesis and ketolysis 0.4971191053150586 0.7192357698912107 0.4719956633968494 1.0 0.9614854562430624 6 P35610,P23786 2 |
| Estrogen receptor pathway 0.6250081541490252 0.7174341266203932 0.4731062687275167 1.0 0.9614854562430624 3 Q9HCL2 1 |
| Canonical and noncanonical notch signaling 0.7457996266334802 0.6851799328273663 0.4932303851829189 1.0 0.9614854562430624 2 P55081 1 |
| Canonical nfkb pathway 0.7457996266334794 0.6851799328273629 0.4932303851829211 1.0 0.9614854562430624 2 O14920 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.7457996266334794 0.6851799328273629 0.4932303851829211 1.0 0.9614854562430624 2 O14920 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.7457996266334794 0.6851799328273629 0.4932303851829211 1.0 0.9614854562430624 2 O14920 1 |
| Sting pathway in kawasakilike disease and covid19 0.7457996266334794 0.6851799328273629 0.4932303851829211 1.0 0.9614854562430624 2 O14920 1 |
| Relationship between inflammation cox2 and egfr 0.5089110587243916 0.6705275999953629 0.5025215182188862 1.0 0.9614854562430624 5 P31751 1 |
| Glucocorticoid receptor pathway 0.4832966511054835 0.6531330903356611 0.5136704811083668 1.0 0.9614854562430624 7 P27105 1 |
| Alzheimers disease and mirna effects 0.3790072893240511 0.6367366772826701 0.5242963787729269 1.0 0.9614854562430624 86 P12236,O95197,P49721,P45880,Q9NQC3,Q92542,Q9Y277,P12235,P21796,P16615 10 |
| Pkcgamma calcium signaling pathway in ataxia 0.7268201617921689 0.6187704780219848 0.5360675731754099 1.0 0.9645136209676328 2 P23634 1 |
| Apoptosis modulation and signaling 0.4557547281650042 0.5391323809997104 0.5897955138432909 1.0 0.980062873622784 15 O95831,Q9NR28,Q07820 3 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4553343301938471 0.5209744510240708 0.6023845694750627 1.0 0.9821340434436032 11 P04035,P37268,Q9BWD1 3 |
| Nodlike receptor nlr signaling pathway 0.5692094875225353 0.5193114192264191 0.6035435914767335 1.0 0.9821340434436032 3 O14920 1 |
| Cholesterol biosynthesis pathway 0.4519413872920383 0.5094699371661222 0.610422865388232 1.0 0.9821340434436032 13 P04035,Q16850,Q15800 3 |
| 7oxoc and 7betahc pathways 0.4492725557735558 0.4901321437657686 0.6240403936643104 1.0 0.9821340434436032 10 Q9UBM7,O14734,Q15125,P22307,P61916,O15118 6 |
| Sarscov2 b117 variant antagonises innate immune activation 0.6869943995021826 0.4875065562414039 0.6258993978123919 1.0 0.9821340434436032 2 Q7Z434 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.6810827629122594 0.469099552423139 0.6389984789853189 1.0 0.9821340434436032 2 P08183 1 |
| Ppar signaling pathway 0.4405482809118151 0.4646825910826012 0.6421587770751302 1.0 0.9821340434436032 16 Q15067,O00767,P23786,O15254,P33121,P22307,Q16822,Q9UKU0 8 |
| Nephrotic syndrome 0.4421765324672654 0.4600215219518669 0.6455007725380266 1.0 0.9821340434436032 13 O75844,Q14108 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.675482265090231 0.4519459365529062 0.6513079304307152 1.0 0.9821340434436032 2 Q15758 1 |
| Nad metabolism 0.4908140042343858 0.4456652967639397 0.6558390359175974 1.0 0.982936700447928 4 P43490 1 |
| Phosphoinositides metabolism 0.4320426440621568 0.4179126510996897 0.6760109824725549 1.0 0.9908200184279112 6 Q9NTJ5 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.4475241357832475 0.4108742750498667 0.68116472644451 1.0 0.9942276662427042 5 P18031,O15111,P06730,P06753 4 |
| Proximal tubule transport 0.4288164830023153 0.3928687085432222 0.6944164541017592 1.0 0.9983095196681542 10 P04920 1 |
| Immune response to tuberculosis 0.4291199827781754 0.3390687448078047 0.7345579432381637 1.0 1.0 5 P23458,Q03518 2 |
| 15q112 copy number variation syndrome 0.4592154420921525 0.336984584465214 0.7361285209716737 1.0 1.0 4 Q96CW5,Q9BSJ2,Q7L576 3 |
| Vitamin b12 disorders 0.5107376283846898 0.3367922361020569 0.7362735262095348 1.0 1.0 3 Q99707,P22033 2 |
| Interactome of polycomb repressive complex 2 prc2 0.5020230314347991 0.312486198055223 0.7546710506447942 1.0 1.0 3 Q9Y2W1,Q9NYF8 2 |
| Development of ureteric collection system 0.4458281444582793 0.2940881320535577 0.7686905593597453 1.0 1.0 4 Q12948,P35222,P05556 3 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.4933849953533809 0.2892434092929827 0.7723951149897443 1.0 1.0 3 O14920 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.4015476717517497 0.2774404915686082 0.7814418936398442 1.0 1.0 8 P61020,P31943 2 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.6104542626011246 0.2758448419226602 0.7826672404591188 1.0 1.0 2 Q8TD30 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.4721444133208928 0.2358953952274014 0.81351384150946 1.0 1.0 3 P48729,P35222 2 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.3898069433864934 0.2236133314479635 0.8230581893378937 1.0 1.0 9 Q12834,Q9UJX6 2 |
| Hedgehog signaling pathway wp47 0.5827629122588733 0.2154719102319203 0.8293994100981437 1.0 1.0 2 O00422 1 |
| Supression of hmgb1 mediated inflammation by thbd 0.4603157961235155 0.2086539161311495 0.834718417814533 1.0 1.0 3 O14920 1 |
| Oxysterols derived from cholesterol 0.3840981013601964 0.2058957463058381 0.8368723482208591 1.0 1.0 8 Q9UBM7,P22307,O14734,Q15125 4 |
| Nad biosynthetic pathways 0.390708027628449 0.2023420641032794 0.8396493176104682 1.0 1.0 5 P43490 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.4126950916709676 0.1974991282207429 0.843436963583807 1.0 1.0 4 P23458 1 |
| Lncrnamediated mechanisms of therapeutic resistance 0.5706285003111453 0.1920127479378016 0.8477322198161767 1.0 1.0 2 P08183 1 |
| Sars coronavirus and innate immunity 0.4475663913105999 0.181356372322285 0.8560878608238776 1.0 1.0 3 P23458 1 |
| Steroid biosynthesis 0.5544492843808356 0.1636200340517911 0.8700302723625748 1.0 1.0 2 P51659 1 |
| Erk pathway in huntingtons disease 0.4354186118892028 0.1573879812132821 0.8749390850120962 1.0 1.0 3 P55210,P42858 2 |
| Robo4 and vegf signaling pathways crosstalk 0.4120759414877151 0.1170080885578772 0.9068536437712305 1.0 1.0 3 P12931,O94813 2 |
| Complement system in neuronal development and plasticity 0.3638758268655762 0.1093136039998645 0.9129537568257552 1.0 1.0 11 O43464,Q9NR28 2 |
| Gdnfret signaling axis 0.369863013698628 0.0959989365698329 0.9235214171573708 1.0 1.0 4 Q12948,P35222,O94813 3 |
| Allograft rejection 0.3576562446578556 0.0856652648755963 0.9317325152022552 1.0 1.0 11 P08183,P10321,P01889,P08670,P04439 5 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3624434814893488 0.0809892876568171 0.9354504717298576 1.0 1.0 18 Q9UJX6,Q9UKG1 2 |
| Interactions between loxl4 and oxidative stress pathway 0.3589663760896615 0.0747700935797181 0.9403976370561118 1.0 1.0 4 Q9BQ95,Q16543,Q8TAG9 3 |
| Hair follicle development organogenesis part 2 of 3 0.3722377840024879 0.0650533185693006 0.9481315480418372 1.0 1.0 3 P35222,P05556 2 |
| Serotonin and anxiety 0.458929682638461 0.0591220056574379 0.9528549313170942 1.0 1.0 2 Q08209 1 |
| Bile acids synthesis and enterohepatic circulation 0.4352831362787943 0.0470826773462614 0.9624473335004532 1.0 1.0 2 P51114 1 |
| Praderwilli and angelman syndrome 0.340505144995327 0.0402120603088978 0.9679240626717992 1.0 1.0 9 Q15154,P42771,P04637,Q05086,Q7L576,Q00534,P11802,P06400 8 |
| Mitochondrial gene expression 0.3327486377708165 0.0401175366226753 0.9679994208527928 1.0 1.0 5 O00411,Q08209,Q9P2K5 3 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.3098942128189145 0.0272363858645361 0.9782711947394678 1.0 1.0 2 P05556 1 |
| Spinal cord injury 0.349985526207012 0.0243391911436725 0.9805820523694404 1.0 1.0 20 Q9NQC3,Q08722 2 |
| Tryptophan metabolism 0.3456570095961162 0.0186490291248508 0.9851210900391264 1.0 1.0 15 P51648 1 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3302338072661706 0.0170917793207483 0.9863633971075708 1.0 1.0 8 P23458,O14920,Q7Z434 3 |
| Apoptosis 0.3418532292781758 0.0095182617180773 0.9924056406010556 1.0 1.0 14 Q07820 1 |
|
|
